NCT07112053 2026-03-09
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
Phase 2 Recruiting
Clinical Trials
1 trialsAnatomic Stage IV Breast Cancer AJCC v8 × Cyclin-Dependent Kinase Inhibitor p18 × 90 days × Clear all